Kadmon, a biotech company founded by the once-jailed former CEO of ImClone, is spinning out its gene therapy division on the path to a long-promised IPO, touting a novel approach to the fast-moving field.

…read more

Source: Waksal’s new biotech spins out its gene therapy biz with an IPO in mind


0 No comments